DE2631947B2 - Verwendung von ätherischen ölen und Äthylalkohol - Google Patents

Verwendung von ätherischen ölen und Äthylalkohol

Info

Publication number
DE2631947B2
DE2631947B2 DE19762631947 DE2631947A DE2631947B2 DE 2631947 B2 DE2631947 B2 DE 2631947B2 DE 19762631947 DE19762631947 DE 19762631947 DE 2631947 A DE2631947 A DE 2631947A DE 2631947 B2 DE2631947 B2 DE 2631947B2
Authority
DE
Germany
Prior art keywords
essential oils
ethyl alcohol
preservation
preparations
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762631947
Other languages
German (de)
English (en)
Other versions
DE2631947A1 (de
Inventor
Josef Dr. Lingnau
Roland Dr. Rupp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE19762631947 priority Critical patent/DE2631947B2/de
Priority to GB2921577A priority patent/GB1578541A/en
Priority to FR7721703A priority patent/FR2358162A1/fr
Priority to JP8308677A priority patent/JPS5312415A/ja
Priority to BE179340A priority patent/BE856811A/xx
Priority to ES460743A priority patent/ES460743A1/es
Priority to ES460773A priority patent/ES460773A1/es
Priority to AT513477A priority patent/AT361631B/de
Priority to NL7707936A priority patent/NL7707936A/xx
Publication of DE2631947A1 publication Critical patent/DE2631947A1/de
Publication of DE2631947B2 publication Critical patent/DE2631947B2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19762631947 1976-07-15 1976-07-15 Verwendung von ätherischen ölen und Äthylalkohol Withdrawn DE2631947B2 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE19762631947 DE2631947B2 (de) 1976-07-15 1976-07-15 Verwendung von ätherischen ölen und Äthylalkohol
GB2921577A GB1578541A (en) 1976-07-15 1977-07-12 Preserving liquid antacid medicinal formulations
FR7721703A FR2358162A1 (fr) 1976-07-15 1977-07-13 Compositions pharmaceutiques basiques renfermant un preservateur
JP8308677A JPS5312415A (en) 1976-07-15 1977-07-13 Medical recipe and method
BE179340A BE856811A (fr) 1976-07-15 1977-07-14 Compositions pharmaceutiques basiques renfermant un preservateur
ES460743A ES460743A1 (es) 1976-07-15 1977-07-14 Procedimiento para la obtencion de preparados medicinales con ph acido.
ES460773A ES460773A1 (es) 1976-07-15 1977-07-15 Perfeccionamientos en maquinas lavadoras de tamborprocedimiento para la obtencion de preparados medicinales con ph alcalino. para car-ga frontal.
AT513477A AT361631B (de) 1976-07-15 1977-07-15 Konservierungsmittel fuer basische, gegebenen- falls antazid wirksame, arzneimittelzu- bereitungen
NL7707936A NL7707936A (nl) 1976-07-15 1977-07-15 Werkwijze voor het conserveren van basische farmaceutische preparaten.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762631947 DE2631947B2 (de) 1976-07-15 1976-07-15 Verwendung von ätherischen ölen und Äthylalkohol

Publications (2)

Publication Number Publication Date
DE2631947A1 DE2631947A1 (de) 1978-01-19
DE2631947B2 true DE2631947B2 (de) 1980-11-27

Family

ID=5983131

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762631947 Withdrawn DE2631947B2 (de) 1976-07-15 1976-07-15 Verwendung von ätherischen ölen und Äthylalkohol

Country Status (8)

Country Link
JP (1) JPS5312415A (US06373033-20020416-M00071.png)
AT (1) AT361631B (US06373033-20020416-M00071.png)
BE (1) BE856811A (US06373033-20020416-M00071.png)
DE (1) DE2631947B2 (US06373033-20020416-M00071.png)
ES (1) ES460743A1 (US06373033-20020416-M00071.png)
FR (1) FR2358162A1 (US06373033-20020416-M00071.png)
GB (1) GB1578541A (US06373033-20020416-M00071.png)
NL (1) NL7707936A (US06373033-20020416-M00071.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0132472A1 (en) * 1983-07-20 1985-02-13 Warner-Lambert Company Medicated products containing a magnesium trisilicate adsorbent with a medicament drug adsorbed thereon

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57106942A (en) * 1980-12-24 1982-07-03 Nissan Motor Co Ltd Multiple operation switch device for vehicle
JPS57106941A (en) * 1980-12-24 1982-07-03 Nissan Motor Co Ltd Multiple operation switch device for vehicle
US4643898A (en) * 1983-07-20 1987-02-17 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of nutritional supplements and laxatives
US4632823A (en) * 1983-07-20 1986-12-30 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of appetite suppressants
US4632821A (en) * 1983-07-20 1986-12-30 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of decongestants
US4647450A (en) * 1983-07-20 1987-03-03 Warner-Lambert Company Chewing gum compositions containing magnesium trisilicate absorbates
US4649041A (en) * 1983-07-20 1987-03-10 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antinauseants
US4650663A (en) * 1983-07-20 1987-03-17 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antitussives
US4643892A (en) * 1983-07-20 1987-02-17 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of analgesics
US4647459A (en) * 1983-07-20 1987-03-03 Warner-Lambert Company Confectionery compositions containing magnesium trisilicate adsorbates
US4632822A (en) * 1983-07-20 1986-12-30 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antiasmatics
US4642231A (en) * 1983-07-20 1987-02-10 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of antihistamines
US4647449A (en) * 1983-07-20 1987-03-03 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates of alkaloids
JPS6126127A (ja) * 1984-07-17 1986-02-05 Nec Corp 電子黒板装置
JPS6196812A (ja) * 1984-10-17 1986-05-15 Murata Mfg Co Ltd 電子部品
DE3612086A1 (de) * 1986-04-10 1987-10-15 Bayer Ag Konservierte antacida-zubereitungen
EP0480054B1 (en) * 1990-03-30 1996-10-02 Morimoto, Yasunori Percutaneously absorbable composition of morphine hydrochloride
GB2408933A (en) * 2003-12-12 2005-06-15 Reckitt Benckiser Healthcare Antimicrobial composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB810537A (en) * 1957-09-04 1959-03-18 Upjohn Co Sweetening composition
US3039928A (en) * 1960-03-17 1962-06-19 Abbott Lab Stable aqueous isoproteronol compositions
US3313686A (en) * 1962-08-24 1967-04-11 Squibb & Sons Inc Palatable antitussive agent-resin complex
DE1518663A1 (de) * 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
DE1617542A1 (de) * 1967-04-26 1971-04-08 Isnel Afife Dipl Chem Dr Verfahren zum Herstellen von stabilen Loesungen von Lecithin,besonders Soyabohnenlecithin,in waessrigem,zuckerhaltigen Alkohol
CH524372A (de) * 1969-01-29 1972-06-30 Ciba Geigy Ag Verfahren zur Herstellung von stabilen Elixieren, welche therapeutisch verwendbare tricyclische basische Wirkstoffe in Form ihrer Mononatriumpamoate enthalten
US3714363A (en) * 1970-08-11 1973-01-30 Sandoz Ag Substituted amino guanidine as anti-diabetic agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0132472A1 (en) * 1983-07-20 1985-02-13 Warner-Lambert Company Medicated products containing a magnesium trisilicate adsorbent with a medicament drug adsorbed thereon

Also Published As

Publication number Publication date
AT361631B (de) 1981-03-25
NL7707936A (nl) 1978-01-17
FR2358162A1 (fr) 1978-02-10
ATA513477A (de) 1980-08-15
JPS5312415A (en) 1978-02-03
BE856811A (fr) 1978-01-16
ES460743A1 (es) 1978-05-01
GB1578541A (en) 1980-11-05
DE2631947A1 (de) 1978-01-19
FR2358162B1 (US06373033-20020416-M00071.png) 1980-02-08

Similar Documents

Publication Publication Date Title
DE2631947B2 (de) Verwendung von ätherischen ölen und Äthylalkohol
DE69932313T2 (de) Wässerige flüssige zubereitungen
EP0117888B1 (de) Flüssigzubereitungen von Dihydropyridinen, ein Verfahren zu ihrer Herstellung, sowie ihre Verwendung bei der Bekämpfung von Erkrankungen
DE602005002495T2 (de) Injizierbare Formulierung mit Natriumdiclofenac, Beta-Cyclodextrin und einem Polysorbat
DE68904922T2 (de) Piroxicam in waessrigen loesungen enthaltende arzneizubereitungen und verfahren zu deren herstellung.
DE2708152B2 (de) Pharmazeutisches Trägermaterial für die örtliche Aufbringung auf Schleimhäuten
DE69627170T2 (de) Nichtwässrige abführmittel für den kolon
AT409081B (de) Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
DE3783024T2 (de) Topische ofloxacin enthaltende zubereitung.
CH414063A (de) Röntgenkontrastmittel
DE4139017C2 (de) Wäßrige Piroxicam-Lösungen und Verfahren zu ihrer Herstellung
EP0773022A2 (de) Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure
DE68902300T2 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DE3715918C2 (US06373033-20020416-M00071.png)
DE2416216C2 (de) Oral verabreichbares pharmazeutisches Gemisch
DE19522693A1 (de) Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung
DE3042975A1 (de) Mikrodispersion mit einem wirkstoff und/oder einem reagens in salzform als disperser phase
DE3509741A1 (de) Orale dosierungsform von etoposid
EP0871691B1 (de) Verfahren zur reinigung von alkoxylierten fetten
DE2422760A1 (de) Stabilisierte catecholaminloesungen
DE68903597T2 (de) Weichkapselzubereitung von natriumpicosulfat.
DE2723936A1 (de) Ophthalmische loesung fuer die glaucom-behandlung
DE2461570C3 (de) Arzneimittel für die Behandlung bakterieller Infektionen der Augen und/oder der Ohren und Verfahren zu ihrer Herstellung
DE3831514A1 (de) Ph-neutrale waessrige loesungen von chinoloncarbonsaeuren
DE2102889C3 (de) Verwendung von SuIf adimidin und Pyrimethamin

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
8263 Opposition against grant of a patent
8230 Patent withdrawn